BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33438102)

  • 1. Dietary modulations of folic acid affect the development of diethylnitrosamine induced hepatocellular carcinoma in a rat model.
    Sharma R; Ali T; Negi I; Das A; Duseja A; Kaur J
    J Mol Histol; 2021 Apr; 52(2):335-350. PubMed ID: 33438102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor suppressor genes are differentially regulated with dietary folate modulations in a rat model of hepatocellular carcinoma.
    Sharma R; Ali T; Kaur J
    Mol Cell Biochem; 2021 Jan; 476(1):385-399. PubMed ID: 32974832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Standardization of diethylnitrosamine-induced hepatocellular carcinoma rat model with time based molecular assessment.
    Ghufran H; Azam M; Mehmood A; Butt H; Riazuddin S
    Exp Mol Pathol; 2021 Dec; 123():104715. PubMed ID: 34699901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of diethylnitrosamine-induced hepatocellular carcinoma in a rat model by combination therapy of diacerein and gold nanoparticles: a histopathological and immunohistochemical study.
    Baokbah TAS
    J Histotechnol; 2023 Mar; 46(1):5-16. PubMed ID: 36214360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
    Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
    J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats.
    Khan F; Khan TJ; Kalamegam G; Pushparaj PN; Chaudhary A; Abuzenadah A; Kumosani T; Barbour E; Al-Qahtani M
    BMC Complement Altern Med; 2017 Aug; 17(1):418. PubMed ID: 28830415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol interferes with N-nitrosodiethylamine-induced hepatocellular carcinoma at early and advanced stages in male Wistar rats.
    Rajasekaran D; Elavarasan J; Sivalingam M; Ganapathy E; Kumar A; Kalpana K; Sakthisekaran D
    Mol Med Rep; 2011; 4(6):1211-7. PubMed ID: 21850372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.
    Ding YF; Wu ZH; Wei YJ; Shu L; Peng YR
    J Cancer Res Clin Oncol; 2017 May; 143(5):821-834. PubMed ID: 28238064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maotai ameliorates diethylnitrosamine-initiated hepatocellular carcinoma formation in mice.
    Yi X; Long L; Yang C; Lu Y; Cheng M
    PLoS One; 2014; 9(4):e93599. PubMed ID: 24690765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of two selenium sources on hepatocarcinogenesis and several angiogenic cytokines in diethylnitrosamine-induced hepatocarcinoma rats.
    Liu JG; Zhao HJ; Liu YJ; Liu YW; Wang XL
    J Trace Elem Med Biol; 2012 Oct; 26(4):255-61. PubMed ID: 22425635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asarone and metformin delays experimentally induced hepatocellular carcinoma in diabetic milieu.
    Das BK; Choukimath SM; Gadad PC
    Life Sci; 2019 Aug; 230():10-18. PubMed ID: 31121175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Piperlongumine inhibits diethylnitrosamine induced hepatocellular carcinoma in rats.
    Kumar A; Naithani M; Kumar N; Singh N; Agrawal S; Sharma A; Thapliyal S; Singh J; Handu S
    Hum Exp Toxicol; 2022; 41():9603271211073593. PubMed ID: 35113675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of NF-κB/PI3K/AKT signaling pathway in the protective effect of prunetin against a diethylnitrosamine induced hepatocellular carcinogenesis in rats.
    Li G; Qi L; Chen H; Tian G
    J Biochem Mol Toxicol; 2022 May; 36(5):e23016. PubMed ID: 35239232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effects of thymoquinone on the initiation stage of diethylnitrosamine hepatocarcinogenesis in rats.
    Ibrahim S; Fahim SA; Tadros SA; Badary OA
    J Biochem Mol Toxicol; 2022 Aug; 36(8):e23078. PubMed ID: 35437842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK/integrin signaling pathway.
    Fu C; Zhang Y; Xi WJ; Xu K; Meng F; Ma T; Li W; Wu L; Chen Z
    J Ethnopharmacol; 2023 May; 308():116191. PubMed ID: 36731809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
    Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
    Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triterpenoids principle of Wedelia calendulacea attenuated diethynitrosamine-induced hepatocellular carcinoma via down-regulating oxidative stress, inflammation and pathology via NF-kB pathway.
    Verma A; Singh D; Anwar F; Bhatt PC; Al-Abbasi F; Kumar V
    Inflammopharmacology; 2018 Feb; 26(1):133-146. PubMed ID: 28608141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonorchis sinensis infection contributes to hepatocellular carcinoma progression in rat.
    Qi Y; Hu J; Liang J; Hu X; Ma N; Xiang B
    Parasitol Res; 2022 Dec; 121(12):3403-3415. PubMed ID: 36266591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemopreventive and Therapeutic Efficacy of Enhalus acoroides against Diethylnitrosamine Induced Hepatocellular Carcinoma in Wistar Albino Rats.
    Amudha P; Jayalakshmi M; Vidya R; Poojitha BN
    Appl Biochem Biotechnol; 2023 Apr; 195(4):2597-2617. PubMed ID: 35106713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model.
    Nota T; Kageyama K; Yamamoto A; Kakehashi A; Yonezawa H; Jogo A; Sohgawa E; Murai K; Ogawa S; Miki Y
    Acad Radiol; 2023 Jan; 30(1):30-39. PubMed ID: 35680546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.